Cited by 88Cardiac pacing and defibrillation studiesCardiac electrophysiology and arrhythmiasECG Monitoring and Analysis

Prognostic Value and Temporal Behavior of the Planar QRS-T Angle in Patients With Nonischemic Cardiomyopathy

Pavri, Behzad B., Hillis, Matthew B., Subačius, Haris, Brumberg, Genevieve E., Schaechter, Andi, Levine, Joseph H., Kadish, Alan·2008·Circulation

Abstract

Background— The planar QRS-T angle can be easily obtained from standard 12-lead ECGs, but its predictive ability is not established. We sought to determine the predictive ability of the planar QRS-T angle in patients with nonischemic cardiomyopathy and to assess QRS-T angle behavior over time. Methods and Results— Baseline QRS-T angles from 455 patients in the Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) trial were measured. All patients had nonischemic cardiomyopathy, New York Heart Association class I to III heart failure, and nonsustained ventricular tachycardia or frequent ventricular ectopy. The primary end point (a composite of total mortality, appropriate implantable cardioverter-defibrillator shock, or resuscitated cardiac arrest) occurred in 25 of 172 patients (14.5%) with a QRS-T angle ≤90° and in 72 of 283 patients (25.4%) with a QRS-T angle >90° (hazard ratio, 1.93; 95% confidence interval, 1.23 to 3.05; P =0.002). A QRS-T angle >90° remained a significant predictor of the primary end point ( P =0.039) after adjustment for treatment group, age, gender, QRS duration, left bundle-branch block, left ventricular ejection fraction, New York Heart Association class III, atrial fibrillation, and diabetes mellitus. The secondary end point (total mortality) occurred in 17 of the 172 patients (9.9%) with a QRS-T angle ≤90° and in 49 of the 283 patients (17.3%) with a QRS-T angle >90° (hazard ratio, 1.79; 95% confidence interval, 1.03 to 3.10; P =0.016). A sample of 152 patients with multiple follow-up ECGs was analyzed to assess temporal QRS-T angle behavior. Changes in the QRS-T angle correlated with changes in left ventricular ejection fraction and QRS duration over time ( P <0.001). Conclusions— A planar QRS-T angle >90° is a significant predictor of a composite end point of death, appropriate implantable cardioverter-defibrillator shock, or resuscitated cardiac arrest in nonpaced, mild to moderately symptomatic patients with nonischemic cardiomyopathy with frequent or complex ventricular ectopy. QRS-T angles changed predictably with left ventricular ejection fraction and QRS duration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.107.733451

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In nonischemic cardiomyopathy, a planar QRS-T angle >90° has important prognostic value.

    “In nonischemic cardiomyopathy a planar QTS-T angle >90 • was found to have important prognostic value.42”

    From The Year of 2008 in Electrocardiology (2010) · cites this paper as [42]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 34 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Costantini O, Rosenbaum DS, Hohnloser SH, Kirk M, Lerman B, Baker II J, Sethuraman B, Dettmer M, for the ABCD Investigators. The Alternans Before Cardioverter Defibrillator (ABCD) trial: a noninvasive strategy for primary prevention of sudden cardiac death using T-wave alternans. Circulation. 2006;114:2426.

Cited by

Sorted by citations

Authors
Pavri, B. B., Hillis, M. B., Subačius, H., Brumberg, G. E., Schaechter, A., Levine, J. H., & Kadish, A.
Affiliations
  • Thomas Jefferson University Hospital (US)
  • From the Department of Medicine, Division of Cardiology, Thomas Jefferson University Hospital, Philadelphia, Pa (B.B.P., M.B.H., G.E.B.); Department of Medicine, Division of Cardiology, Northwestern Memorial Hospital, Chicago, Ill (H.S., A.S., A.K.); and Department of Medicine, Division of Cardiology, St Francis Hospital, Roslyn, NY (J.H.L.).
Corresponding author
Pavri, Behzad B.
Venue
Circulation
Published
2008-06-24
Volume
117
Issue
25
Pages
3181-3186
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2085211243
Cited by
88
References
34
Citations by year
2026: 3 · 2024: 1 · 2023: 8 · 2022: 9 · 2021: 6 · 2020: 8 · 2019: 7 · 2018: 6 · 2017: 3 · 2016: 6 · 2015: 5 · 2014: 6 · 2013: 5 · 2012: 5
FWCI
2.43
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • Touro Scholar (Touro College) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › ECG Monitoring and Analysis
Keywords
non-ischemic cardiomyopathy, prognosis, implantable cardioverter-defibrillator, ventricular arrhythmias, mortality, left ventricular ejection fraction, QRS duration, heart failure, non-sustained ventricular tachycardia, ventricular ectopy, ECG biomarkers
MeSH terms
Adult, Aged, Aged, 80 and over, Electrocardiography, Follow-Up Studies, Humans, Middle Aged, Cardiomyopathies, Predictive Value of Tests, Prognosis, Risk Factors, Multivariate Analysis, Randomized Controlled Trials as Topic, Treatment Outcome, Defibrillators, Implantable, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review